TrialJAMA cardiology2018

Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.

Brian A Bergmark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.